<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang HJ</submitter><funding>"Food Functionality Evaluation program" under the Ministry of Agriculture, Food and Rural Affairs and partly the Korea Food Research Institute.</funding><pagination>3751</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11547720</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(21)</volume><pubmed_abstract>&lt;h4>Background/objectives&lt;/h4>&lt;i>Schisandra chinensis&lt;/i> Fructus (SCF) is a traditional medicinal herb containing lignans that improves glucose metabolism by mitigating insulin resistance. We aimed to investigate the therapeutic potential and action mechanism of SCF for Alzheimer's disease (AD) using a network pharmacology analysis, followed by experimental validation in an AD rat model.&lt;h4>Methods&lt;/h4>The biological activities of SCF's bioactive compounds were assessed through a network pharmacology analysis. An AD rat model was generated by infusing amyloid-β peptide (Aβ) (25-35) into the hippocampus to induce Aβ accumulation. The AD rats were fed either 0.5% dextrin (AD-Con) or 0.5% SCF (AD-SCF group) in a high-fat diet for seven weeks. The rats in the normal/control group received an </pubmed_abstract><journal>Nutrients</journal><pubmed_title>Efficacy and Mechanism of &amp;lt;i&amp;gt;Schisandra chinensis&amp;lt;/i&amp;gt; Fructus Water Extract in Alzheimer's Disease: Insights from Network Pharmacology and Validation in an Amyloid-β Infused Animal Model.</pubmed_title><pmcid>PMC11547720</pmcid><funding_grant_id>2023-2</funding_grant_id><pubmed_authors>Zhang T</pubmed_authors><pubmed_authors>Jang DJ</pubmed_authors><pubmed_authors>Kim MJ</pubmed_authors><pubmed_authors>Hur HJ</pubmed_authors><pubmed_authors>Park S</pubmed_authors><pubmed_authors>Yang HJ</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy and Mechanism of &amp;lt;i&amp;gt;Schisandra chinensis&amp;lt;/i&amp;gt; Fructus Water Extract in Alzheimer's Disease: Insights from Network Pharmacology and Validation in an Amyloid-β Infused Animal Model.</name><description>&lt;h4>Background/objectives&lt;/h4>&lt;i>Schisandra chinensis&lt;/i> Fructus (SCF) is a traditional medicinal herb containing lignans that improves glucose metabolism by mitigating insulin resistance. We aimed to investigate the therapeutic potential and action mechanism of SCF for Alzheimer's disease (AD) using a network pharmacology analysis, followed by experimental validation in an AD rat model.&lt;h4>Methods&lt;/h4>The biological activities of SCF's bioactive compounds were assessed through a network pharmacology analysis. An AD rat model was generated by infusing amyloid-β peptide (Aβ) (25-35) into the hippocampus to induce Aβ accumulation. The AD rats were fed either 0.5% dextrin (AD-Con) or 0.5% SCF (AD-SCF group) in a high-fat diet for seven weeks. The rats in the normal/control group received an </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-18T14:07:21.271Z</modification><creation>2025-04-07T00:04:21.436Z</creation></dates><accession>S-EPMC11547720</accession><cross_references><pubmed>39519586</pubmed><doi>10.3390/nu16213751</doi></cross_references></HashMap>